These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 8364941

  • 21. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
    Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1336-41. PubMed ID: 2201252
    [Abstract] [Full Text] [Related]

  • 22. Imipenem/cilastatin as empirical treatment of severe infections in compromised patients.
    Biglino A, Bonasso M, Gioannini P.
    J Chemother; 1991 Jan; 3 Suppl 1():208-12. PubMed ID: 12041767
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, Baudard M, Legrand O, Rio B, Delmer A, Zittoun R.
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients.
    Liu CY, Wang FD.
    Chemotherapy; 1989 Mar; 35 Suppl 2():16-22. PubMed ID: 2692982
    [Abstract] [Full Text] [Related]

  • 30. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A, Meli EZ, Mazzocchi P, Speranza V.
    Scand J Infect Dis; 1997 Mar; 29(5):503-8. PubMed ID: 9435041
    [Abstract] [Full Text] [Related]

  • 31. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S.
    Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
    [Abstract] [Full Text] [Related]

  • 32. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
    Rolston KV, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L.
    Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
    Piyasirisilp S, Premprawat W, Thamlikitkul V.
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S117-25. PubMed ID: 20364566
    [Abstract] [Full Text] [Related]

  • 34. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
    Schmitt DV, Leitner E, Welte T, Lode H.
    Infection; 2006 Jun; 34(3):127-34. PubMed ID: 16804655
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Helzerman P.
    Clin Ther; 1992 Jun; 14(1):97-109. PubMed ID: 1576632
    [Abstract] [Full Text] [Related]

  • 36. Postpartum endometritis: efficacy and tolerability of two antibiotic regimens.
    Gonik B.
    Clin Ther; 1992 Jun; 14(1):83-9. PubMed ID: 1576630
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
    de la Rubia J, Montesinos P, Martino R, Jarque I, Rovira M, Vázquez L, López J, Batlle M, de la Cámara R, Juliá A, Lahuerta JJ, Debén G, Díaz J, García R, Sanz MA.
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):512-6. PubMed ID: 19285640
    [Abstract] [Full Text] [Related]

  • 40. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM, Carlson L, Tkaczewski I, McCracken GH, Buchanan GR.
    Pediatr Infect Dis J; 2001 Mar; 20(3):362-9. PubMed ID: 11303851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.